教育经历： 2011.9 - 2014.07 中山大学附属第一医院，肿瘤学(放射治疗方向)，博士 2012.9 - 2012.12 美国Albert Einstein医学院Beth Israel癌症中心，Clinical Observer 2004.9 - 2007.7 中山大学肿瘤防治中心，肿瘤学(放射治疗方向)，硕士 1998.9 - 2003.7 郑州大学，临床医学，学士 工作经历： 2014.07-至今 中山大学附属第一医院放射治疗科工作 2010.07-2011.08 中山大学附属第五医院放疗科，住院医师 2007.08-2010.07 中山大学肿瘤防治中心，放射肿瘤学专科培训医师。 代表作: 1. Induction chemotherapy regimen of docetaxel plus cisplatin versus docetaxel, cisplatin plus fluorouracil followed byconcurrent chemoradiotherapy in locoregionally advanced nasopharyngeal carcinoma: Preliminary results of an open-label.noninferiority, multicentre, randomised, controlled phase 3 trial. Lancet Eclinicalmedicine, 2022; IF=17.0332. Pretreatment BMI as an independent prognostic factor in patients with locoregionally advanced NPC treated with chemoradiotherapy: Findings from a randomized trial. EJC, 2013 ; IF=10.002 3. Association between Pretreatment Serum High-density Lipoprotein Cholestero and Treatment Outcomes in Patients withLocoregionally Advanced Nasopharyngeal Carcinoma Treated with Chemoradiotherapy: Findings from a RandomisedTrialJOC, 2019 ; IF=4.478